Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, Surgery Type, Device Type, Dosage Form, Route of Administration, End-User

Description

List of Tables

The Global Gastroesophageal Reflux Disease Devices Market is forecasted to grow significantly, with a projected USD 5,856.66 million in 2023 at a CAGR of 13.64% and expected to reach a staggering USD 14,352.81 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Gastroesophageal Reflux Disease Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Gastroesophageal Reflux Disease Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Diagnostic Devices, Esophagoscopes & Gastroscopes, Fundoplication Devices, Manometry System, PH Monitoring System, Radiofrequency Ablation Devices, Sphincter Augmentation Devices, Treatment Devices, and Ultrasonic Surgical Endostapler. The Diagnostic Devices is projected to witness significant market share during forecast period.

Based on Procedure Type, market is studied across Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation, and Radiofrequency Thermal Ablation. The Radiofrequency Thermal Ablation is projected to witness significant market share during forecast period.

Based on Surgery Type, market is studied across Invasive and Non-Invasive. The Invasive is further studied across Linx Reflux Management and Medigus Ultrasonic Surgical Endostapler. The Non-Invasive is further studied across Endocinch Endolumminal Gastroplication, Endoscopic Plicator System, EsophyX, Plexiglas Poly-Methyl-Methacrylate Microspheres, and Stretta. The Non-Invasive is projected to witness significant market share during forecast period.

Based on Device Type, market is studied across Bravo Reflux Testing System, Digitrapper reflux testing system, LINX Management System, MUSE -Medigus Ultrasonic Surgical Endostapler, and Stretta Therapy. The LINX Management System is projected to witness significant market share during forecast period.

Based on Dosage Form, market is studied across Liquid and Solid. The Liquid is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Oral and Parenteral. The Parenteral is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Government, Hospitals, and Medical Practitioners. The Government is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Gastroesophageal Reflux Disease Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Gastroesophageal Reflux Disease Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Gastroesophageal Reflux Disease Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Gastroesophageal Reflux Disease Devices Market?

4. What is the competitive strategic window for opportunities in the Global Gastroesophageal Reflux Disease Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Gastroesophageal Reflux Disease Devices Market?

6. What is the market share of the leading vendors in the Global Gastroesophageal Reflux Disease Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Gastroesophageal Reflux Disease Devices Market?

Product Code: MRR-925E8149CF0F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Gastroesophageal Reflux Disease Devices Market, by Product Type, 2022 vs 2030
4.3. Gastroesophageal Reflux Disease Devices Market, by Procedure Type, 2022 vs 2030
4.4. Gastroesophageal Reflux Disease Devices Market, by Surgery Type, 2022 vs 2030
4.5. Gastroesophageal Reflux Disease Devices Market, by Device Type, 2022 vs 2030
4.6. Gastroesophageal Reflux Disease Devices Market, by Dosage Form, 2022 vs 2030
4.7. Gastroesophageal Reflux Disease Devices Market, by Route of Administration, 2022 vs 2030
4.8. Gastroesophageal Reflux Disease Devices Market, by End-User, 2022 vs 2030
4.9. Gastroesophageal Reflux Disease Devices Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising aging population across the world
  - 5.1.1.2. Growing obese population and their preference for surgeries
  - 5.1.1.3. Surge in adoption among diagnostic centers and private clinics
- 5.1.2. Restraints
  - 5.1.2.1. Availability of alternative such as proton pump inhibitors
- 5.1.3. Opportunities
  - 5.1.3.1. Robust innovation and launch of new advanced products in the market
  - 5.1.3.2. Ongoing trend of self-medication and awareness of the disease
- 5.1.4. Challenges
  - 5.1.4.1. Decreased acceptability of devices an dearth of standard regulatory approval
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Gastroesophageal Reflux Disease Devices Market, by Product Type

6.1. Introduction
6.2. Diagnostic Devices
6.3. Esophagoscopes & Gastroscopes
6.4. Fundoplication Devices
6.5. Manometry System
6.6. PH Monitoring System
6.7. Radiofrequency Ablation Devices
6.8. Sphincter Augmentation Devices
6.9. Treatment Devices
6.10. Ultrasonic Surgical Endostapler

7. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

7.1. Introduction
7.2. Diagnostic Procedures
7.3. Fundoplication Procedures
7.4. Magnetic Sphincter Augmentation
7.5. Radiofrequency Thermal Ablation

8. Gastroesophageal Reflux Disease Devices Market, by Surgery Type

8.1. Introduction
8.2. Invasive
- 8.2.1. Linx Reflux Management
- 8.2.2. Medigus Ultrasonic Surgical Endostapler
8.3. Non-Invasive
- 8.3.1. Endocinch Endolumminal Gastroplication
- 8.3.2. Endoscopic Plicator System
- 8.3.3. EsophyX
- 8.3.4. Plexiglas Poly-Methyl-Methacrylate Microspheres
- 8.3.5. Stretta

9. Gastroesophageal Reflux Disease Devices Market, by Device Type

9.1. Introduction
9.2. Bravo Reflux Testing System
9.3. Digitrapper reflux testing system
9.4. LINX Management System
9.5. MUSE -Medigus Ultrasonic Surgical Endostapler
9.6. Stretta Therapy

10. Gastroesophageal Reflux Disease Devices Market, by Dosage Form

10.1. Introduction
10.2. Liquid
10.3. Solid

11. Gastroesophageal Reflux Disease Devices Market, by Route of Administration

11.1. Introduction
11.2. Oral
11.3. Parenteral

12. Gastroesophageal Reflux Disease Devices Market, by End-User

12.1. Introduction
12.2. Government
12.3. Hospitals
12.4. Medical Practitioners

13. Americas Gastroesophageal Reflux Disease Devices Market

13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Gastroesophageal Reflux Disease Devices Market

14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Gastroesophageal Reflux Disease Devices Market

15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape

16.1. FPNV Positioning Matrix
16.2. Market Share Analysis, By Key Player
16.3. Competitive Scenario Analysis, By Key Player

17. List of Company Mentioned

18. Appendix

18.1. Discussion Guide
18.2. License & Pricing